Literature DB >> 26700977

Conservative surgical treatment of adenomyosis to improve fertility: Controversial values, indications, complications, and pregnancy outcomes.

Kuan-Hao Tsui1, Fa-Kung Lee2, Kok-Min Seow3, Wei-Chun Chang4, Jia-Wei Wang5, Shee-Uan Chen6, Hsiang-Tai Chao7, Min-Shyen Yen7, Peng-Hui Wang8.   

Abstract

Uterine adenomyosis was first reported in the 19(th) century and early 20(th) century; von Rokitansky described it in 1860. Since then, the general clinical, pathological, and radiologic findings and potentially useful management methods have been reviewed in many studies. Some authors commented that conservative surgical treatment is impracticable as it is not possible to isolate the adenomyotic tissue adequately; therefore, the authors suggested that hysterectomy is the only rational and complete procedure. There is more evidence supporting the advantages of conservative uterine-sparing surgery in providing not only more effective symptom relief, but also longer durable symptom control for symptomatic women with uterine adenomyosis, because the main problem secondary to uterine adenomyosis, dysmenorrhea, can be improved significantly, up to 80%. Menorrhea was also improved in more than two-thirds of patients after type I uterine-sparing surgery, and half of the patients saw benefit in symptom control after type II conservative uterine-sparing surgery. In addition, there was no negative impact on reproductive performance after conservative uterine-sparing surgery, and in fact, reproductive performance seemed to be improved compared with that after medical treatment-not only was there a higher cumulative pregnancy rate, but also a higher cumulative final successful delivery rate. However, there is no doubt that the data supporting the above-mentioned benefits for symptomatic women with uterine adenomyosis after conservative uterine-sparing surgery are limited, suggesting that the benefit may be moderate. In fact, one of the main indications for surgery is temporary pain relief in women seeking spontaneous conception. However, the effect of surgery on pain is usually only temporarily satisfactory, and the risk of complications varies according to the type of lesion extirpated. In light of this, an extensive review of this topic addressing conservative surgical treatment for adenomyosis to improve fertility, including controversial values, indications, complications, and pregnancy outcomes, might be very important, and might help physicians in managing these patients in the future.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  adenomyosis; conservative surgical treatment; controversy

Mesh:

Year:  2015        PMID: 26700977     DOI: 10.1016/j.tjog.2015.05.003

Source DB:  PubMed          Journal:  Taiwan J Obstet Gynecol        ISSN: 1028-4559            Impact factor:   1.705


  7 in total

1.  Elevated plasma levels of lysophosphatidic acid and aberrant expression of lysophosphatidic acid receptors in adenomyosis.

Authors:  Bicheng Yang; Liqun Wang; Xiaoju Wan; Yunjun Li; Xiaohong Yu; Yunna Qin; Yong Luo; Feng Wang; Ouping Huang
Journal:  BMC Womens Health       Date:  2017-11-25       Impact factor: 2.809

2.  Adenomyosis: Back to the future?

Authors:  Z Ferraz; N Nogueira-Martins; F Nogueira-Martins
Journal:  Facts Views Vis Obgyn       Date:  2017-03

3.  A comparison of surgical outcomes between robot and laparoscopy-assisted adenomyomectomy.

Authors:  Jung In Shim; Eun-Hye Jo; Miseon Kim; Mi Kyoung Kim; Mi-La Kim; Bo Seoung Yun; Seok Ju Seong; Yong Wook Jung
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

4.  Relapse after conservative surgery combined with triptorelin acetate versus conservative surgery only in women with focal adenomyosis: study protocol for a multicenter, prospective, randomized controlled trial.

Authors:  Wenwen Wang; Xiangyi Ma; Wei Zhang; Zhiying Li; Yan Wang; Zhiying Yu; Chunlian Zhang; Li Hong; Ruoyu Luo; Hui Xing; Wuliang Wang; Qingfen Yue; Jia Wei; Minli Zhang; Shixuan Wang
Journal:  Trials       Date:  2020-04-28       Impact factor: 2.279

5.  Recommendations for the surgical treatment of endometriosis Part 2: deep endometriosis †‡¶.

Authors: 
Journal:  Facts Views Vis Obgyn       Date:  2020-03-27

6.  ITRAQ-based proteomics analysis of tanshinone IIA on human ectopic endometrial stromal cells of adenomyosis.

Authors:  Yong Luo; Zeng-Ming Li; Li-Ping Li; Yang Zou; Xiao-Yun Xu; Zi-Yu Zhang; Fa-Ying Liu; Yan Xiong; Lei Wan
Journal:  Arch Gynecol Obstet       Date:  2021-01-20       Impact factor: 2.344

7.  Recommendations for the surgical treatment of endometriosis. Part 2: deep endometriosis.

Authors:  Joerg Keckstein; Christian M Becker; Michel Canis; Anis Feki; Grigoris F Grimbizis; Lone Hummelshoj; Michelle Nisolle; Horace Roman; Ertan Saridogan; Vasilios Tanos; Carla Tomassetti; Uwe A Ulrich; Nathalie Vermeulen; Rudy Leon De Wilde
Journal:  Hum Reprod Open       Date:  2020-02-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.